Journal

Neurobiology of Disease

0969-9961 · Elsevier BV

50 verified public works

Browse all journals →

Plasma PINK1/Parkin ratio and ATF5 as potential biomarkers associated with dyskinesia in Parkinson's disease

2026 · 0 citations

When tau goes electric: The first report of a positive correlation between tau burden and ex vivo hyperexcitability in human epileptic hippocampal slices

2026 · 0 citations

Enhancing astrocytic GAT-3 in zona incerta diminishes fear memory generalization through remodeling neural network

2026 · 0 citations

Altered striatal acetylcholine dynamics in a model of Parkinson's disease and L-DOPA-induced dyskinesia

2026 · 0 citations

SHANK3 regulates nuclear hnRNP K and oxidative stress-associated DNA damage signaling in neurons

2026 · 0 citations

Neurovascular-metabolic coupling links hearing loss to cognitive impairment: Evidence from GABA and cerebral blood flow in presbycusis

2026 · 0 citations

Cellular senescence is an early feature and therapeutic target in amyotrophic lateral sclerosis TDP-43Q331K mice

2026 · 0 citations

Erratum to “The PINK1-VCP-p47 pathway protects against tau-induced dendritic shrinkage in cortical neurons through interaction with STIP1” [Neurobiol. Dis. 229 (2026) 107592]

2026 · 0 citations

Maternal edible THC consumption alters offspring neurodevelopment and emotional behavior in rhesus macaques

2026 · 0 citations

Corrigendum to “Activation of ABCC1 transporter ameliorates synaptic dysregulation in Tay-Sachs disease neuron” [Neurobiol. Dis. 216 (2025) 107099]

2026 · 0 citations

TDP-43 and ALS - what's wrong with my membranes?

2026 · 0 citations

Dysregulation of the Schwann cell GABAergic system and Aβ-fibers conduction abnormalities in the sciatic nerve of the mdx mouse model of Duchenne muscular dystrophy

2026 · 0 citations

PERK deficiency amplifies molecular, structural, and network vulnerability to repetitive mild traumatic brain injury

2026 · 0 citations

Editorial Board

2026 · 0 citations

Multiple system atrophy-derived α-synuclein fibrils are more potent and display oligodendrocyte cell tropism compared to Parkinson's disease-derived fibrils

2026 · 0 citations

Single-cell spatial transcriptomics reveals rewiring of RPE and Müller glia signaling toward photoreceptors following outer segment disruption in Prph2C213Y mice

2026 · 0 citations

Circular RNAs in amyotrophic lateral sclerosis

2026 · 0 citations

Gait-cycle-locked cortico-subthalamic signatures underlying freezing of gait and their modulation in Parkinson's disease

2026 · 0 citations

Selective impairment of long-term depression in accumbal D1R+ MSNs involves calcium-permeable AMPARs in early Alzheimer's disease

2026 · 0 citations

Dopamine D2 receptor dependent and independent structural, intrinsic and synaptic adaptations in experimental parkinsonism

2026 · 0 citations

Microglial CX3CR1 signaling mediates synaptic pruning in degenerative cervical myelopathy

2026 · 0 citations

Insulin like growth factor and cytokine signalling predict future cognitive impairment in Parkinson's disease

2026 · 0 citations

Chronic hypertension and social isolation disrupt the blood-brain barrier and memory in a sex-dependent manner

2026 · 0 citations

Bi-compartmental CSF–serum analysis of NfL and GFAP differentiates central and peripheral pathology in neuroinfectious diseases: A monocentric real-world cohort study

2026 · 0 citations

The role of PANoptosis regulatory networks in acute neurological injury

2026 · 0 citations

Peripheral neuropathy in a mouse model lacking GBA1 in Schwann cells

2026 · 0 citations

Sex-dependent protective effects of microglial tumor necrosis factor on post-stroke inflammation and myelin injury

2026 · 0 citations

Neuromodulators of orbitofrontal cortex function: A review of endocannabinoid, neurotrophin, and cell adhesion systems

2026 · 0 citations

Gene-environment interaction between perinatal oxytocin exposure and Pten mutation shapes epigenetic reprogramming of oxytocin signaling and behavior in mice

2026 · 0 citations

Dysregulated metabolism in neurodevelopmental disorders: From glycolytic gene variants to metabolic reprogramming and therapeutic perspectives

2026 · 0 citations